No products in the cart.
The 2016 Nobel Prize winner, Yoshinori Ohsumi, described autophagy as “a fundamental and an essential[...]
A new study provides reassuring information about the short-term and long-term safety of denosumab,[...]
In a new study published in the International Academic Journal Journal of Clinical Oncology, the[...]
Giving monkeys two powerful anti-HIV antibodies immediately after infection with an HIV-like virus enabled the[...]
Innovations to prevent heart disease will take centre stage at EuroPrevent 2017 in Malaga, Spain. EuroPrevent[...]
Takeda Pharmaceutical Company Limited, (“Takeda”) today announced that the interim findings from the GEMINI Long-Term[...]
Pembrolizumab (trade name: Keytruda) was initially introduced for the treatment of melanoma. Since July 2016,[...]
Rituximab may be an attractive treatment option for patients with relapsing-remitting multiple sclerosis (MS), suggest[...]
Welcome to AntibodyPlus!